Never forget that the stock market has a very short memory, Jim Cramer cautioned his Mad Money viewers Friday. Just because the markets staged a strong rally Friday, rest assured that next week's sessions will depend on a totally different new cycles.
Cramer's game plan for next week starts on Monday with Citigroup (C - Get Report) and Goldman Sachs (GS - Get Report) . Cramer said it will be hard for these banks to top JPMorgan Chase's (JPM - Get Report) strong results.
Next, on Tuesday, we hear from UnitedHealth Group (UNH - Get Report) and Johnson & Johnson (JNJ - Get Report) . Cramer said investors have given up on health insurers and J&J needs to put its baby powder-talc issues behind them. Cramer was bullish on IBM (IBM - Get Report) , CSX (CSX - Get Report) and United Airlines (UAL - Get Report) , as well as Netflix (NFLX - Get Report) , all of which also report.
Wednesday brings more earnings, this time from PepsiCo (PEP - Get Report) and Morgan Stanley (MS - Get Report) , two Cramer favorites, along with the fabulous Abbott Labs (ABT - Get Report) and ASML (ASML - Get Report) . Cramer said he'd buy the first three, but preferred Lam Research (LRCX - Get Report) over ASML.
Then on Thursday, the earnings parade continues with Honeywell (HON - Get Report) and Danaher (DHR - Get Report) , both of which Cramer would buy. He said to steer clear of Union Pacific (UNP - Get Report) and the Pinterest IPO.
Introducing TheStreet Courses: Financial titans Jim Cramer and Robert Powell are bringing their market savvy and investing strategies to you. Learn how to create tax-efficient income, avoid top mistakes, reduce risk and more. With our courses, you will have the tools and knowledge needed to achieve your financial goals. Learn more about TheStreet Courses on investing and personal finance here.
Executive Decision: Bristol-Myers Squibb
For his "Executive Decision" segment, Cramer sat down with Giovanni Caforio, chairman and CEO of Bristol-Myers Squibb (BMY - Get Report) , the pharma giant that continues its quest to acquire Celgene (CELG - Get Report) .
Caforio said the today's shareholder vote brings the two companies one step closer to a deal. He remained confident that the deal will be closed in the third quarter of this year.
Caforio continued by explaining that the real value behind the combined company are its pipelines, which will deliver six new drugs in the first two years. Three of those have already be filed with the FDA, he noted, which is great news for both patients and shareholders. The combine company, he said, will provide sustainable growth for the long term.
When asked about the financial side of the deal, Caforio said Bristol will still maintain a lot of financial flexibility with strong cash flows to pay down debt quickly, starting from day one.
Cramer remained a believer in the Bristol-Myers story, saying the time to buy the stock is not when it's rallying, but when shares go on sale like they are right now.
Cramer and the AAP team are focusing on earnings this week. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts Plus.
Pinning Down Pinterest
There's another big IPO coming next week, and Cramer's took a look at whether Pinterest will become another Lyft (LYFT) or if it will make shareholders a lot of money.
Cramer said that Pinterest is a neat concept and is a great platform for advertisers. This visual discovery search engine is almost profitable and grew its user base 22% last year. The company has accelerating revenue growth, expanding gross margins and is seeing strong growth as it expands overseas.
But as with all IPOs, Cramer said the decision whether to buy Pinterest comes down to valuation. At the expected price of $17 a share, Pinterest would be valued at a discount to Snap (SNAP - Get Report) , but at a slight premium to Twitter (TWTR - Get Report) . Additionally, at $17 a share, the deal would be priced less than the company's latest round of funding, giving shares a solid foundation on which to build.
Cramer said this price seems like the perfect balance for Pinterest, and those who can get in on the IPO itself should most certainly do so. He advised against buying shares in the aftermarket, however, as things could get dicey as they did for Lyft just a few short weeks ago.
Off the Tape: The Retail Sector
In his "Off The Tape" segment, Cramer sat down with Matt Boss, Managing Director of Dept. Stores and Softlines at JPMorgan Chase and the organizer of this week's JPMorgan retail conference.
Boss said there's a lot to like in the retail sector right now. He said many retailers are seeing tough comparisons from 2018, which included tax reform tailwinds, but after a slow start to the year due to weather, the consumer has returned. Boss added that this year's conference saw a lot of confidence in the consumer and the big themes included value, convenience and innovation.
Among the standouts for Boss were discounters like Five Below (FIVE - Get Report) , Dollar General (DG - Get Report) , Ollie's Bargain Outlet (OLLI - Get Report) and Burlington Stores (BURL - Get Report) , all long-time Cramer favorites as well. When it comes to growth, Boss said Lululemon Athletica (LULU - Get Report) continues to deliver, while the leader in the innovation camp is Nike (NKE - Get Report) .
On Real Money, Cramer keys in on the companies and CEOs he knows best. Get more of his insights with a free trial subscription to Real Money.
Worried You Missed the Move?
In his "No-Huddle Offense" segment, Cramer gave viewers some ideas for what to do if they missed today's monster moves with Walt Disney (DIS - Get Report) , JPMorgan Chase and Anadarko Petroleum (APC - Get Report) .
Cramer said he remains a big fan of Disney, but wouldn't chase it at these levels. Instead we suggested buying Viacom (VIA.B) or CBS (CBS - Get Report) , or perhaps Apple (AAPL - Get Report) or Netflix (NFLX - Get Report) , both of which traded lower today.
As for JPMorgan, Cramer said this remains the best bank to own as shares are inexpensive. Finally, Cramer said it's too late to buy Anadarko, but there are certainly other oil producers that could be takeover targets.
Cramer was bearish on Philip Morris International (PM - Get Report) , Bunge (BG - Get Report) , Greenbrier Companies (GBX - Get Report) , LCI Industries (LCII - Get Report) and AbbVie (ABBV - Get Report) .
Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.
To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.